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The Cannabinoid Receptor 
Interacting Proteins 1 of zebrafish 
are not required for morphological 
development, viability or fertility
Laura Fin, Giorgia Bergamin  , Roberto A. Steiner  & Simon M. Hughes  
The Cannabinoid Receptor Interacting Protein 1 (Cnrip1) was discovered as an interactor with the 
intracellular region of Cannabinoid Receptor 1 (CB1R, also known as Cnr1 or CB1). Functional assays in 
mouse show cannabinoid sensitivity changes and Cnrip1 has recently been suggested to control eye 
development in Xenopus laevis. Two Cnrip1 genes are described in zebrafish, cnrip1a and cnrip1b. In situ 
mRNA hybridisation revealed accumulation of mRNA encoding each gene primarily in brain and spinal 
cord, but also elsewhere. For example, cnrip1b is expressed in forming skeletal muscle. CRISPR/Cas9 
genome editing generated predicted null mutations in cnrip1a and cnrip1b. Each mutation triggered 
nonsense-mediated decay of the respective mRNA transcript. No morphological or behavioural 
phenotype was observed in either mutant. Moreover, fish lacking both Cnrip1a and Cnrip1b both 
maternally and zygotically are viable and fertile and no phenotype has so far been detected despite 
strong evolutionary conservation over at least 400 Myr.
The discovery of (−)-trans-Δ9-tetrahydrocannabinol (THC) as the major psychoactive component of marijuana 
(Cannabis sativa)1 and subsequent cloning of the THC receptor2 helped to identify the endogenous cannabinoid 
system (eCS). The eCS is a signalling network responding to endogenous lipid transmitters (endocannabinoids) 
that bind to the G-protein coupled cannabinoid receptors CB1R and CB2R3. These receptors act via Gαi/o binding 
to their second and third intracellular loops and C-terminal 8th helix to initiate signalling events typical of this 
class of transducing proteins, such as inhibition of adenylyl cyclase and activation of MAPK and FAK4, 5. CB1R 
has also been suggested to affect PI3K and PKB signalling and a variety of ion channels3, 6. Endocannabinoids 
are frequently produced post-synaptically in response to neurotransmitter signalling and act retrogradely on 
pre-synaptic terminals to attenuate pre-synaptic depolarisation and diminish further neurotransmitter release, 
forming a negative feedback loop3, 7. The eCS is involved in numerous pathological conditions, ranging from 
neurological disorders, such as Parkinson’s, Huntington’s and Alzheimer’s diseases8, to gastrointestinal, cardiovas-
cular and reproductive disorders9 and is also potentially involved in relief of pain, chemotherapy-induced nausea 
and vomiting, and anorexia10. It thus has potential for therapeutic drug development11.
To understand the biochemical mechanism of endocannabinoid action and find possible drug targets, screens 
have been performed for proteins interacting with CB1R12–14. Two alternative splicing variant proteins, named 
CRIP1a and CRIP1b, deriving from the human Cannabinoid Receptor Interacting Protein 1 gene (CNRIP1)12 have 
been reported to bind to the conserved C-terminal intracellular portion of CB1R, a region thought to be critical 
for receptor activation, sensitivity and recycling15, 16. Human CRIP1a and CRIP1b share identical N-termini, 
but diverge after residue 110 (Fig. 1a). The longer CRIP1a isoform (164 amino acids in human) is conserved 
across vertebrates and invertebrates, whereas CRIP1b (128 amino acids in human) is restricted to certain pri-
mates17. Functionally, CRIP1a, but not CRIP1b, has been reported to modulate CB1R-mediated tonic inhibition 
of voltage-gated Ca2 + channels12 and recent evidence has indicated that CRIP1a can compete with β-arrestins for 
the C-terminal region of CB1R, suggesting a role of internalization of the receptor18.
Neuronal activity, endocannabinoid and D2 dopamine receptor (D2R) signalling can all regulate CNRIP1 
expression19–21. Over-expression of CNRIP1 in rat dorsal striatum led to reduced ERK phosphorylation, decrease 
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in transcript levels of certain opioid peptide precursors and the up-regulation of the opioid receptor DOR1 at 
both mRNA and protein level, mimicking effects observed when either CB1R or D2R were knocked-down21. 
Further over-expression studies have implicated CNRIP1 in CB1R signalling and turnover18, 22–24. Knockdown 
of CNRIP1 protein in a neuronal cell line can increase plasma membrane CB1R, alter G-protein subtype pref-
erence, augment basal phosphor-ERK level and enhance ERK phosphorylation in response to the CB1R agonist 
CP55940, but not to certain other CB1R agonists25. These data suggest the hypothesis that a role of CNRIP1 is 
modulation of endocannabinoid signalling through CB1R. An important observation, however, is that whereas 
CB1R is primarily expressed in neurons of the central and peripheral nervous systems26–30, CNRIP1 is expressed 
more broadly (http://www.ebi.ac.uk/gxa). Western blot analyses confirm that mouse CNRIP1 proteins are present 
in brain but also widely in heart, lung, kidney, intestine, testis, spleen, liver and muscle12. Association of CNRIP1 
promoter hypermethylation with colorectal and liver cancer and lymphoma has suggested the gene is a promising 
biomarker and may function in non-neural tissues31–34. Antisense morpholino knockdown of Cnrip1 in Xenopus 
has been reported to cause brain and also eye defects early in development35, even though the eye lacks abundant 
Cnrip1 and CB1R in adult mouse36. Moreover, a CNRIP1 gene is found in species that lack CB1R, such as the 
diploblast sea anemone Nematostella vectensis17. Thus, CNRIP1 may have other functions independent of CB1R.
Here, we report the analysis of CNRIP1 expression and function in the zebrafish. Zebrafish have duplicate 
cnrip1a and cnrip1b genes expressed widely during early development. CRISPR/Cas9-mediated mutation of each 
gene leads to viable and fertile fish with no obvious phenotype. Double mutant animals are also viable and fertile, 
showing that CNRIP1 proteins are not essential for life.
Results
Zebrafish Cnrip1 genes. Two genes encoding Cnrip1 homologues were discovered in the zebrafish genome 
(Zv10). Cnrip1a, located on Chromosome 1, has three coding exons predicting a 162 amino acid protein with, 
respectively, 60% and 59% identity with the 164 amino acids of human CRIP1a and mouse CNRIP1. The region 
of greatest divergence was in the central region of the predicted proteins. The second gene, cnrip1b, is located on 
Chromosome 13, also has three exons and 162 amino acids with 69% identity with Cnrip1a and 59% identity 
to mammalian CNRIP1 (Fig. 1a). Identity between the two zebrafish paralogue cDNAs was 72% in the cod-
ing region, yielding 93% similarity at the amino acid level, with differences primarily in their N terminal 28 
amino acids. Analysis in GeneTree (ensemble.org) shows that each gene clusters next to a cavefish orthologue 
as the sister groups to euteleost cnrip1a and cnrip1b clusters, consistent with the known teleost-specific genome 
Figure 1. Cnrip1 genes in zebrafish. (a) Amino acid sequence alignment of Cnrip1a and Cnrip1b with the two 
splice variants of the single human CNRIP1 gene, named CRIP1a and CRIP1b. Distinct exons are shown in 
alternating black and blue font (red indicates amino acids coded by two exons). Comparing both zebrafish genes 
and CRIP1a asterisk indicates identity and colon similarity between all three, full stop similarity between any 
two. Bold indicates identity between CRIP1a and CRIP1b. (b) Synteny of adjacent genes in vertebrate CNRIP1 
loci. Colours link homologous genes.
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duplication37. These groups cluster together and branch basally from the single amniote/amphibian CNRIP1 gene 
cluster, following known evolutionary relationships.
Synteny analysis confirms the homology of both zebrafish genes with CNRIP1 of human (Fig. 1b). Human 
and mouse genes have PPP3R1, PNO1, WDR92, CD1 and ETAA1 genes downstream and PLEK, FBXO48 and 
APLF genes upstream. Zebrafish cnrip1a has ppp3r1b and etaa1 downstream and two fbxo48 homologues and aplf 
upstream. Cnrip1b has ppp3r1a, pno1, wdr92 downstream and plek upstream. Thus, almost all flanking genes are 
conserved across ≥ 400 Myr of evolution, suggesting conserved regulation.
Although human CNRIP1 RNA can be alternatively spliced, yielding proteins named CRIP1a and CRIP1b12 
(Fig. 1a), no evidence of alternative splicing of either zebrafish gene was apparent in ENSEMBL. BLAST searches 
with the human alternate third exon of CRIP1b failed to identify sequences on zebrafish Chromosome 1 or 13. 
Indeed, neither zebrafish gene had significant homology with the alternate third exon of CRIP1b. This suggests 
that sub-functionalisation of an ancestral alternatively-spliced gene into two genes each of which encodes one 
splice variant does not explain the evolutionary retention of two Cnrip1 genes in teleosts. Cnrip1a and cnrip1b 
have 24% and 28% identity to the last three exons of a C. elegans orthologue, F29A7.4, which has two additional 
5′ exons encoding an N-terminal extension. Taken together, these data indicate strong conservation of structure, 
regulation and probably function of CNRIP1 across the vertebrates and possibly beyond.
Expression of cnrip1a and cnrip1b transcripts. To analyse the expression pattern of cnrip1a and cnrip1b 
genes in zebrafish, embryos at several developmental stages were subjected to whole mount in situ hybridisation 
(Fig. 2; quantitative evidence of reproducibility for all experiments is presented in Table S1). Cnrip1a mRNA was 
detected throughout the embryo at around 10 hpf (Fig. 2a; Table S1). Hybridisation with a cnrip1a sense probe, in 
contrast, showed no significant staining. Consistent with a previous report38, at 24 and 48 hpf, cnrip1a was most 
highly expressed in the brain and spinal cord (Fig. 2a; Table S1). At 24 hpf, cnrip1a shows strongest expression 
in telencephalon, anterior and post-optic commissure, pineal gland, retinal ganglion cells, other head ganglia 
and neuron clusters in the hindbrain and in spinal cord (Fig. 2a; Table S1). At 48 hpf, the brain is widely stained. 
Olfactory receptors appear to be stained flanking the telencephalon. In hindbrain, cnrip1a mRNA is most abun-
dant in radial glia on the sides of the rhombomeres. Signal in radial neuronal cells in the retina around the lens 
was suggestive of retinal ganglion cells. The spinal cord appeared less strongly stained at 48 hpf compared to 24 
hpf (Fig. 2a; Table S1), but when 48 hpf fish tails were stained overnight separately from heads, a pattern similar to 
the one observed at 24 hpf appeared (data not shown). In general, cnrip1a mRNA was detected in many regions 
where post-mitotic neurons were abundant.
Differential gene expression could provide initial information on the possible additional functions of Cnrip1b 
in other body regions. Cnrip1b mRNA appears at around 10 hpf and, at this developmental stage, the pattern is 
Figure 2. Accumulation of mRNAs from cnrip1a and cnrip1b genes. Whole mount in situ mRNA hybridisation 
of embryos at the indicated stages for antisense probes to cnrip1a (a) and cnrip1b (b). Lateral views (first two 
images in each panel) are anterior to top dorsal to left, except 24 hpf in which anterior is to left and dorsal to top. 
Dorsal views (remaining images) are anterior to left flatmounts (a) or wholemount (b), except panel a top right, 
which is a wholemount montage with anterior to top right. Sense control in inset in panel a top right is anterior 
to right dorsal to bottom. Quantitative evidence of reproducibility is given in Table S1. tel telencephalon, FB 
forebrain, MB midbrain, HB hindbrain, SC spinal cord, pf pectoral fin. Bars = 100 µm.
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similar to the one observed for cnrip1a mRNA (Fig. 2b; Table S1). At 24 and 48 hpf, the expression of cnrip1b 
diverges from that of cnrip1a. Cnrip1b is expressed in the brain, the eyes and the spinal cord, but the staining 
remains diffuse, whereas cnrip1a mRNA showed a clear enrichment in regions of post-mitotic neurons concen-
tration (Fig. 2a; Table S1). In addition, unlike cnrip1a, cnrip1b mRNA was detected in developing somites and 
pectoral fins (Fig. 2b; Table S1). Thus, cnrip1b is expressed somewhat differently from cnrip1a, suggesting it could 
have a distinct function.
Mutagenesis of Cnrip1 genes. Zebrafish mutants in cnrip1a and cnrip1b were generated using CRISPR/
Cas9 genome editing (Fig. 3). Embryos from genotyped AB strain parents chosen to lack polymorphism in the 
target region were injected at 1-cell stage with gRNA and Cas9 RNA and these F0 fish outcrossed to similarly 
non-polymorphic wild-type AB to identify F1 fish heterozygous for mutations in each gene. Among 12 mutations 
obtained in one gRNA to cnrip1a, an allele cnrip1akg98 with a 4 bp deletion leading to a frameshift at amino acid 
33 followed by in-frame stop codon after six further amino acids was selected (Fig. 3a). The novel stop codon in 
Figure 3. Mutagenesis of cnrip1a and cnrip1b. (a) Alignments of wild type with each of three mutant alleles 
showing the predicted expressed mutant polypeptide beneath. Bold underline indicates the gRNA target, 
red font the protospacer motif recognised by Cas9, hyphens deleted bases, blue highlight inserted bases and 
asterisks novel stop codons. In the mutant protein sequences, bold text indicates the residual wild type fragment 
and normal font the aberrant polypeptide tail. (b,c). To test for nonsense-mediated decay, about 50 siblings from 
in-crosses of cnrip1a+/kg98 (b) and cnrip1b+/kg101 (c) mutant carriers were subjected to in situ hybridisation for 
the cognate mRNA at the indicated stages, photographed, DNA extracted, PCR performed across the mutant 
locus and genotype confirmed by DNA sequencing as indicated beneath each panel. Quantitative evidence of 
reproducibility is given in Table S1.
www.nature.com/scientificreports/
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this allele is 20 amino acids ( = 60 bp) 5′ to the next in-frame methionine, making ribosomal re-initiation highly 
unlikely because the ribosome footprint on mRNA is only ~28 bp. A second allele, cnrip1akg96, was selected from 
three alleles produced with a distinct gRNA to cnrip1a; in this case a 53 bp insertion caused a frameshift at amino 
acid 47 followed by in-frame stop codon after six further amino acids (Fig. 3a). Beyond this stop codon at 7 and 
19 bp downstream are two additional out of frame AUG codons which are themselves shortly followed by two 
additional stop codons, making in-frame re-initiation of the ribosome highly unlikely. For cnrip1b. among nine 
distinct mutations obtained with the single gRNA, a 10 bp deletion allele cnrip1bkg101 was selected, which led to a 
frameshift at amino acid 31 followed by in-frame stop codon after six further amino acids (Fig. 3a). The nearest 
in-frame AUG codon is 40 bp downstream of the deletion, giving little possibility of ribosomal re-initiation.
For both genes, only mutations that inserted a stop codon as close as possible to the CRISPR target site were 
selected. In this way, only short truncated polypeptides are produced, which are typically unfolded and rapidly 
degraded. Moreover, as the mutant mRNAs lack translation beyond the first coding exon, they were degraded by 
the nonsense-mediated decay pathway39, as revealed by the greatly reduced in situ mRNA hybridisation signal 
observed in mutants (Fig. 3b,c; Table S1). Compared to wild type siblings, significantly less mRNA was also dis-
cerned in heterozygotes (Fig. 3b,c; Table S1).
Embryos homozygous mutant in each of the three alleles developed normally and no morphological abnor-
malities were detected (Fig. 3b,c; Table S1 and data not shown). In particular, eye morphology, pigmentation, 
lens and retina formation appeared normal (Fig. 3b,c; Table S1). From heterozygote in-crosses, an average of 20 
embryos were genotyped at 48 hpf from three independent lays and χ2 tests showed no significant difference from 
expected Mendelian values (Table S1). Sibling larvae were again monitored at 5 dpf and weekly during growth 
in the nursery, but no consistent morphological or behavioural defects were observed in the predicted 25% of 
mutants (Table S1). Larvae were grown to adulthood and mutants (detected from finclip DNA) were observed 
at the expected 25% frequency and were indistinguishable from wild type and heterozygous siblings (Table S1). 
Cnrip1akg98 homozygous mutants survived as well as siblings until at least 19 months of age; cnrip1bkg101 homozy-
gous mutants survived until at least 16 months (Table S1). Both cnrip1akg98 and for cnrip1bkg101 homozygous 
mutants were normally fertile and maternal/zygotic mutants (produced by breeding from a homozygous mutant 
mother) also showed no phenotype (Table S1), eliminating the possibility that Cnrip1 protein placed in the egg 
by a heterozygous mother supressed a more severe phenotype.
Functional analysis of double mutants. Cnrip1akg98 and cnrip1bkg101 carriers were crossed to pro-
duce dual cnrip1akg98/+;cnrip1bkg101/+ heterozygotes, which were in-crossed. Double mutants were observed at 
the expected frequency and again showed no morphological or behavioural defects (Fig. 4a; Table S1). Double 
mutants survived as well as their siblings until at least 15 months of age and, when in-crossed produced normal 
sized lays of healthy and viable larvae that grew to adulthood (Fig. 4b–d; Table S1). No defects in eye, brain, spinal 
cord, body shape and size, muscle, notochord, fins, pigmentation, swim bladder, pectoral fins, jaw, gut peristalsis, 
eating behaviour, eye movement, swimming, shoaling and mating behaviour or fertility were observed. Thus, 
insertion of early stop codons into both Cnrip1 genes of zebrafish yielded healthy and fertile adult fish.
Discussion
The present work demonstrates that homozygous predicted loss of function mutations of all CNRIP1 genes in a 
vertebrate leads to viable and fertile organisms with no discernible characteristics different from wild type. Cnrip1 
expression is observed in the outer plexiform layer (OPL) of the mouse retina36 and morpholino loss of function 
studies have suggested that Xenopus laevis cnrip1 regulates eye development35. However, we detected no eye 
defects in our maternal/zygotic cnrip1a;cnrip1b double mutants. Similarly, although Cnrip1 is expressed in mouse 
heart12, careful analysis of the developing heart revealed no defects and adult mutants did not show increased sud-
den cardiac death. Lastly, CNRIP1 is highly expressed in the nervous system in species from mammals to fish, yet 
no morphological neural deficits or behavioural changes were observed in our mutants. These findings indicate 
that the function of the well-conserved CNRIP1 protein(s) confers a subtle increase in fitness that is not readily 
detected in the unchallenged aquarium environment.
There remains a formal possibility that our mutations, despite creating early stop codons in the first exon, are 
not null, either because the short truncated polypeptides can play some role or because of some kind of riboso-
mal re-initiation or stop codon read-through permits synthesis of a long protein. In the absence of functional 
antibodies recognizing the zebrafish proteins, we cannot be certain that no functional folded Cnrip1 protein 
is synthesised. However, we think this unlikely for several reasons. Firstly, nonsense mediated mRNA decay 
for each gene suggests that exon splice junction complexes are not removed downstream of the in-frame stop 
codons, indicating that ribosomes do not progress normally to the end of the three exon transcripts from each 
gene. Consistent with this view, there are no in-frame methionine codons nearby downstream of the novel stop 
codons that might encourage re-initiation by a stalled ribosome before it dissociates from the mRNA. Secondly, 
the reduced mRNA levels will mean that fewer ribosomal initiation events occur on each transcript and thus the 
absolute number of truncated polypeptides synthesised per unit time is likely lower than that of the full length 
proteins in wild types. Thirdly, the truncated polypeptides are under 40 amino acids in length (compared with 
162 amino acids for each full length protein) and thus are unlikely to create a stable folded domain and will 
therefore be more rapidly degraded than the full length proteins. For these reasons, we suspect our mutants are 
functionally null.
Genomic analysis reveals that the genomes of zebrafish and most other fish contain duplicated copies of a 
clear homologue of the human CNRIP1 gene. This strongly suggests that (a) CNRIP1 is a conserved gene that has 
had an important function in vertebrates for at least 400 Myr, (b) that after the extra teleost genome duplication 
the duplicates developed essential functions sufficiently rapidly for both genes to be retained and well conserved. 
An invertebrate homologue of CNRIP1, F29A7.4, is present in C. elegans, has an ~80 amino acid N-terminal 
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extension compared to vertebrates but is expressed in the ventral nerve cord and various neurons40. Akin to our 
findings in zebrafish, F29A7.4 has not been observed to have a loss of function phenotype in two independent 
RNAi screens (http://www.wormbase.org/species/c_elegans/gene/WBGene00017914).
Figure 4. Maternal zygotic double cnrip1akg98;cnrip1bkg101 mutant fish develop normally. (a) Schematic of crosses 
to generate a cnrip1 double mutant. (b) Darkfield image of 1 dpf double mutant indicating normal complex CNS 
folds (white arrowhead). (c) Differential interference contrast image of 1 dpf double mutant with arrowheads 
indicating normal eye (red), ear (purple), notochord (cyan) and haematopoetic tissue (black). (d) Dorsal, 
lateral and oblique (inset) views of 8 dpf larvae with arrowheads indicating pectoral fins (blue), jaw (turquoise), 
food traversing gut (green), swim bladder (orange) and xanthophores (yellow). Quantitative evidence of 
reproducibility is given in Table S1. All fish shown with anterior to left and dorsal up. Bars = 200 μm.
www.nature.com/scientificreports/
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A consistent characteristic of CNRIP1 family genes, also observed in zebrafish, is strong expression in neu-
ral tissue (recently reviewed41). Both cnrip1a and cnrip1b are expressed in the zebrafish nervous system, with 
cnrip1a mRNA sometimes concentrated in particular regions of neuronal terminal differentiation. Cells in spe-
cific regions of the brain and in placode-derived cranial ganglia express highly. This conserved location of expres-
sion is consistent with the conserved synteny of the chromosomal region around CNRIP1 coding sequence across 
vertebrates. Expression in neurons is consistent with the suggested ability of CNRIP1 to bind to the intracellu-
lar region of CB1R, but does not exclude other functions in neurons. Cnrip1b is expressed more broadly than 
cnrip1a, appearing in muscle and fin tissue in the late embryo. As CB1R is expressed in many tissues, this finding 
could indicate functions beyond neuronal action of endocannabinoids. In future, it will be essential to assess the 
response of cnrip1a and cnrip1b mutant fish to gain and loss of function of endogenous and exogenous cannabi-
noids, as well as explore alternative functional avenues.
Methods
Zebrafish lines and maintenance. Genetically-altered Danio rerio on a primarily AB background were 
created and reared at King’s College London on a 14/10 hr light/dark cycle at 28.5 °C42. All experiments were 
performed in accordance with licences held under the UK Animals (Scientific Procedures) Act 1986 and later 
modifications and conforming to all relevant guidelines and regulations.
In situ mRNA hybridisation. In situ mRNA hybridisation (ISH) was performed as described previ-
ously43, 44. IMAGE clones for both cnrip1a (clone ID: 7149263) and cnrip1b (clone ID: 8760081) genes (Thermo 
Scientific) were grown as in Table S2 and confirmed by sequencing. A PCR reaction was then performed to add 
T3 and T7 RNA polymerase sites to create antisense and sense probes. Generic pDNR-LIB primers were used 
for cnrip1a, while specific primers for cnrip1b were designed. Primers (Integrated DNA Technologies; Table S3) 
were used to amplify template DNA (Table S4), purified using the QIAquick PCR Purification Kit (QIAGEN) and 
digoxigenin-labelled RNA probes synthesised, treated with DNase and purified with the Illustra Microspin G-50 
kit (GE Healthcare).
CRISPR/Cas9 genome editing. Genome editing was adapted from ref. 45. CRISPR target sites in the 
first coding exon were selected with ZiFiT46 and potential off-targets minimized with the specific ZiFiT tool. 
Optimised flanking primers creating a ~120 bp PCR product for High Resolution Melt Analysis (HRM; 20 bp 
each, Tm 60 °C) and 200–400 bp product for DNA sequencing were selected for each gRNA with Primer 3 soft-
ware47 and oligos bought from MWG Eurofins. CRISPR oligos were annealed, ligated into BsaI-digested pDR274 
(Addgene), plasmid DNA purified, sequenced, digested with DraI and the 284 bp fragment gel-purified and used 
to synthesise gRNA with T7 RiboMAX large scale RNA production kit (Promega) which was phenol/ethanol 
purified, quantified by gel and Qubit (Invitrogen), aliquoted in 5 µl samples at 200 ng/µl and stored at −80 °C. 
NotI-HF-linearised pCS2-Cas9 was transcribed using mMessage mMachine SP6 kit (Ambion) and product puri-
fied as for gRNA.
HRMA-selected AB wild-type fish were DNA sequenced over the target loci to avoid polymorphisms, crossed 
and the resulting embryos injected with 1 nl containing 60 ng/µl gRNA, 200 ng/µl Cas9 mRNA and phenol red 
and GFP mRNA to select injected embryos. Twenty morphologically-normal 48 hpf larvae were analysed by 
HRMA to verify mutagenesis, their F0 siblings grown to adulthood and backcross F1 progeny analysed for trans-
mission by HRMA. Mutant loci of F1s were sequenced to identify F0s transmitting mutations of interest, F1 sib-
lings grown to adulthood and F1 heterozygotes identified by HRMA and sequencing of fin-clip DNA. Subsequent 
generations were bred by outcross to non-polymorphic wild-type AB. To generate double mutants, cnrip1a and 
cnrip1b F2 heterozygotes were crossed to obtain F3 progeny in which 25% of fish were dual heterozygotes (cnri-
p1a+/−;cnrip1b+/−). These fish were in-crossed to generate a F4 progeny of which 6.25% were predicted to be 
homozygous for both genes (cnrip1a−/−;cnrip1b−/−).
High resolution melt analysis (HRMA). Total genomic DNA was extracted from single embryos at 24 
or 48 hpf or fin-clip tissue using 100 µl of PeqLab lysis solution (31-401-E) with 20 µg proteinase K incubated at 
55 °C overnight and inactivated at 85 °C for 45 minutes. For the HRMA, 1 µl of each DNA lysate was mixed with 
2× MeltDoctor HRM mix (Life Technologies), forward and reverse HRM primers (0.14 µM) to 32 µl and half 
loaded in duplicate wells on a MicroAmp Optical 384-well plate (Life Technologies), sealed with optical adhesive 
film, centrifuged at maximum speed for 30 seconds on a bench plate centrifuge to eliminate bubbles and HRMA 
performed on a ViiA7 real-time PCR system (Applied Biosystems).
Screening for phenotype. Multiple lays of in-crosses between fish carrying identical or distinct alleles were 
screened for phenotypes. In each lay, about a hundred F2–F4 embryos at 4–10 hpf were monitored for alterations 
in gastrulation, epiboly and formation of the embryonic shield. From 10–36 hpf, defects in somites, myogenesis, 
brain, spinal cord, notochord, eye and heart were screened. Subsequently, alteration in brain, spinal cord, eye, 
heart, cardiovascular system and fin morphology, pigmentation hatching, touch response and swimming patterns 
were analysed. At 96 hpf, larvae were screened again for touch response and motility, defects in pigmentation, 
pectoral fins, jaw, branchial arches, blood, ear, liver and gut. At 5 dpf, larvae were transferred to the nursery, where 
they were monitored on a weekly basis for later developmental defects or behaviour abnormalities.
Statistics. χ2 tests were performed in Excel taking p < 0.05 as significant.
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